ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MAJED MOUDED M.D.

Endocrinology, Diabetes Metabolism

24,997

$1.49M

835
638 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 43%

$60
Average prescription price

Avg: $106

RICHARD HOCHMAN MD

Endocrinology, Diabetes Metabolism

15,706

$804K

523
419 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 43%

$51
Average prescription price

Avg: $106

THOMAS GARTMAN M.D.

Endocrinology, Diabetes Metabolism

15,693

$746K

801
620 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 43%

$48
Average prescription price

Avg: $106

TAMER YACOUB M.D.

Endocrinology, Diabetes Metabolism

14,218

$1.68M

680
447 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 43%

$118
Average prescription price

Avg: $106

WARREN THAU M.D.

Endocrinology, Diabetes Metabolism

12,729

$692K

719
507 are 65+

10%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 43%

$54
Average prescription price

Avg: $106

ZIAD FARAH MD

Endocrinology, Diabetes Metabolism

10,949

$1.11M

795
613 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 43%

$102
Average prescription price

Avg: $106

CHARLES EIL MD

Endocrinology, Diabetes Metabolism

8,738

$1.17M

793
516 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 43%

$134
Average prescription price

Avg: $106

MARC VANDERLEEDEN M.D.

Endocrinology, Diabetes Metabolism

7,932

$532K

441
367 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 43%

$67
Average prescription price

Avg: $106

CHRISTOPHER COAKLEY M.D.

Endocrinology, Diabetes Metabolism

7,206

$755K

364
258 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 43%

$105
Average prescription price

Avg: $106

RAAFAT ATTIA-HANNA M.D.

Endocrinology, Diabetes Metabolism

7,093

$376K

296
136 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 43%

$53
Average prescription price

Avg: $106

BARRY IZENSTEIN M.D.

Endocrinology, Diabetes Metabolism

6,844

$507K

467
401 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 43%

$74
Average prescription price

Avg: $106

ANTONIO GRANFONE MD

Endocrinology, Diabetes Metabolism

6,764

$417K

301
262 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 43%

$62
Average prescription price

Avg: $106

DEEPAK SANAN M.D.

Endocrinology, Diabetes Metabolism

6,704

$451K

342
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 43%

$67
Average prescription price

Avg: $106

JAMES WARSHAW MD, PHD

Endocrinology, Diabetes Metabolism

6,297

$727K

439
271 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 43%

$115
Average prescription price

Avg: $106

ALAN COLE MD

Endocrinology, Diabetes Metabolism

5,885

$430K

402
335 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 43%

$73
Average prescription price

Avg: $106

PAT CHIRASEVEENUPRAPUND MD

Endocrinology, Diabetes Metabolism

5,847

$323K

346
328 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 43%

$55
Average prescription price

Avg: $106

JEROME STARR M.D.

Endocrinology, Diabetes Metabolism

5,764

$784K

316
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 43%

$136
Average prescription price

Avg: $106

KATYA DIVARI M.D.

Endocrinology, Diabetes Metabolism

5,727

$459K

437
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 43%

$80
Average prescription price

Avg: $106

NEIL KOBROSKY MD

Endocrinology, Diabetes Metabolism

5,706

$602K

554
403 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 43%

$105
Average prescription price

Avg: $106

RICHARD HAAS M.D.

Endocrinology, Diabetes Metabolism

5,252

$735K

334
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 43%

$140
Average prescription price

Avg: $106

GERMAN VELASCO M.D.

Endocrinology, Diabetes Metabolism

4,959

$735K

500
341 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 43%

$148
Average prescription price

Avg: $106

KIMBERLY BROWNE-MARTIN M.D.

Endocrinology, Diabetes Metabolism

4,875

$348K

336
262 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 43%

$71
Average prescription price

Avg: $106

MARY DELANEY MD

Endocrinology, Diabetes Metabolism

4,718

$310K

293
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 43%

$66
Average prescription price

Avg: $106

WILLIAM COBB MD

Endocrinology, Diabetes Metabolism

4,558

$584K

358
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 43%

$128
Average prescription price

Avg: $106

ANNA KOZUPA M.D.

Endocrinology, Diabetes Metabolism

4,417

$692K

439
289 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 43%

$157
Average prescription price

Avg: $106

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank